ID

26273

Beschrijving

Study ID: 101468/196 Clinical Study ID: 101468/196 Study Title: 101468/196: A Long-Term, Open-Label Continuation Study of Once Daily Administration of Ropinirole CR Tablets to Patients with Parkinson's Disease who Completed the Previous Ropinirole CR Studies 167 or 164 Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00650104 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Zygara,ZIPEREVE,ZEPREVE,Requip Depot,REQUIP,REPREVE,Modutab,ADARTREL Study Indication : Parkinson DiseaseA Long-Term, Open-Label Continuation Study of Once Daily Adminstration of Ropinirole CR Tablets to Patients with Parkinson's Disease Who Completed the Previous Ropinirole CR Studies - 167 & 164 Ongoing Record: Other (Non-Study) Medication

Trefwoorden

Versies (1)
  1. 15-10-17 15-10-17 -
Houder van rechten

GlaxoSmithKline

Geüploaded op

15 oktober 2017

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY-NC-ND 3.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Concomitant Medication Ropinirole in Parkinson's Disease GSK 101468/196

Engels

Concomitant Medication Ropinirole in Parkinson's Disease GSK 101468/196

1 Formulieren  
Patient Information
Beschrijving

Patient Information

Alias
UMLS CUI-1
C1955348
Patient No.
Beschrijving

Patient Number

Datatype

text

Alias
UMLS CUI [1]
C1830427
Other (Non-Study) Medications
Beschrijving

Other (Non-Study) Medications

Alias
UMLS CUI-1
C2347852
Has the patient taken any concomitant medication(s) (other than study drug) from the Re-Enrollment Screening Visit through the end of the Treatment Period? This CRF will only be used by subjects who have re-enrolled in the study after completion at 36 months.
Beschrijving

Concomitant Medication

Datatype

boolean

Alias
UMLS CUI [1]
C2347852
Medication (Use Generic Name)
Beschrijving

Medication Name

Datatype

text

Alias
UMLS CUI [1]
C2360065
Date started
Beschrijving

Start Date

Datatype

date

Maateenheden
  • dd-mmm-yyyy
Alias
UMLS CUI [1]
C0808070
dd-mmm-yyyy
Date stopped
Beschrijving

End Date

Datatype

date

Maateenheden
  • dd-mmm-yyyy
Alias
UMLS CUI [1]
C0806020
dd-mmm-yyyy
Continuing
Beschrijving

Ongoing Medication

Datatype

boolean

Alias
UMLS CUI [1]
C2826666
Dose (e.g. 10 mg)
Beschrijving

Dosage

Datatype

text

Alias
UMLS CUI [1]
C0178602
Frequency (e.g. tid)
Beschrijving

Medication Frequency

Datatype

text

Alias
UMLS CUI [1]
C3476109
Route
Beschrijving

Administration Route

Datatype

text

Route: If Other, Specify:
Beschrijving

Administration Route: Specification

Datatype

text

Alias
UMLS CUI [1,1]
C0013153
UMLS CUI [1,2]
C2348235
Indication
Beschrijving

Indication

Datatype

text

Alias
UMLS CUI [1]
C3146298
Terug naar het begin van de pagina

Similar models

Concomitant Medication Ropinirole in Parkinson's Disease GSK 101468/196

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
Patient Information
C1955348 (UMLS CUI-1)
Patient Number
Item
Patient No.
text
C1830427 (UMLS CUI [1])
Item Group
Other (Non-Study) Medications
C2347852 (UMLS CUI-1)
Concomitant Medication
Item
Has the patient taken any concomitant medication(s) (other than study drug) from the Re-Enrollment Screening Visit through the end of the Treatment Period? This CRF will only be used by subjects who have re-enrolled in the study after completion at 36 months.
boolean
C2347852 (UMLS CUI [1])
Medication Name
Item
Medication (Use Generic Name)
text
C2360065 (UMLS CUI [1])
Start Date
Item
Date started
date
C0808070 (UMLS CUI [1])
End Date
Item
Date stopped
date
C0806020 (UMLS CUI [1])
Ongoing Medication
Item
Continuing
boolean
C2826666 (UMLS CUI [1])
Dosage
Item
Dose (e.g. 10 mg)
text
C0178602 (UMLS CUI [1])
Medication Frequency
Item
Frequency (e.g. tid)
text
C3476109 (UMLS CUI [1])
Item
Route
text
Administration Route
Code List
Route
CL Item
IV (IV)
CL Item
IM (IM)
CL Item
PO (PO)
CL Item
SC (SC)
CL Item
PR (PR)
CL Item
Sublingual (Sublingual)
CL Item
Inhaled (Inhaled)
CL Item
Topical (Topical)
CL Item
Other (Other)
Item
Route: If Other, Specify:
text
C0013153 (UMLS CUI [1,1])
C2348235 (UMLS CUI [1,2])
Administration Route
Code List
Route: If Other, Specify:
Indication
Item
Indication
text
C3146298 (UMLS CUI [1])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial